Mutant NRAS(Q61) shares signaling similarities across various cancer types – potential implications for future therapies

af Vujic, Igor, Posch, Christian, Sanlorenzo, Martina, Yen, Adam J., Tsumura, Aaron, Kwong, Andrew, Feichtenschlager, Valentin, Lai, Kevin, Arneson, Douglas V., Rappersberger, Klemens, Ortiz-Urda, Susana M.
Udgivet 2014

Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo

af Posch, Christian, Moslehi, Homayoun, Feeney, Luzviminda, Green, Gary A., Ebaee, Anoosheh, Feichtenschlager, Valentin, Chong, Kim, Peng, Lily, Dimon, Michelle T., Phillips, Thomas, Daud, Adil I., McCalmont, Timothy H., LeBoit, Philip E., Ortiz-Urda, Susana
Udgivet 2013